分子量: 1768.189 Da / 分子数: 1 / 由来タイプ: 合成 詳細: THE L-22 PEPTIDE WAS SYNTHESIZED BY SOLID PHASE SYNTHESIS AND PURIFIED BY REVERSE PHASE HPLC
#2: RNA鎖
HIV-1TARRNA
分子量: 9307.555 Da / 分子数: 1 / 由来タイプ: 合成 詳細: RNA WAS TRANSCRIBED IN VITRO FROM DNA OLIGONUCLEOTIDE TEMPLATES WITH T7 RNA POLYMERASE PURIFIED IN HOUSE WITH UNLABELED OR 13C/15N ENRICHED NTPS (ISOTEC) AND PURIFIED BY DENATURING PAGE.
C.D. Schwieters, J.J. Kuszewski, N. TjandraandG.M. Clore
構造決定
NMRPipe
Delaglio, Grzesiek, Vuister, Zhu, PfeiferandBax
解析
TopSpin
BrukerBiospin
collection
TALOS
Cornilescu, DelaglioandBax
データ解析
Sparky
Goddard
peakpicking
X-PLOR NIH
2.16.0
C.D. Schwieters, J.J. Kuszewski, N. TjandraandG.M. Clore
精密化
精密化
手法: simulated annealing / ソフトェア番号: 1 詳細: Structures of the HIV-1 TAR RNA/L-22 complex were calculated with Xplor-NIH. Backbone dihedral angle restraints for the peptide were estimated using chemical shift data and TALOS. Structures ...詳細: Structures of the HIV-1 TAR RNA/L-22 complex were calculated with Xplor-NIH. Backbone dihedral angle restraints for the peptide were estimated using chemical shift data and TALOS. Structures were originally calculated without RDCs to test for convergence and adherence to the NOE data. RDC restraints were then applied as susceptibility anisotropy restraints with a harmonic potential well.